Bifogade filer
PM-Last-day-for-trading-TO1-Emplicure-AB.pdf
Kurs & Likviditet
Prenumeration
Beskrivning
| Land | Sverige |
|---|---|
| Lista | First North Stockholm |
| Sektor | Hälsovård |
| Industri | Läkemedel & Handel |
Today, May 11 2022, is the last day for trading with warrants of series TO1 in Emplicure AB (publ) ("Emplicure" or the "Company"). The subscription period runs up to and including May 13 2022. Each warrant of series TO1 entitles the holder to subscribe for one (1) new share in the Company at a price of SEK 2.09 per share.
Note that warrants that are not exercised on May 13 2022 at the latest or are sold on May 11 2022 at the last, will expire without value. To ensure that warrants of series TO1 do not expire without value, the holder of such warrants must exercise such warrants for subscription of new shares or sell such warrants.
Summarized terms for warrants of series TO1:
Last day of exercise of TO1 for subscription of shares: May 13 2022.
Subscription price: SEK 2.09 per share.
Volume: 9,600,000 warrants of series TO1. If all warrants of series TO1 are exercised, the number of shares in the Company will increase with 9,600,00 shares, and the Company will receive approximately SEK 20.1 million before issuing costs.
Last day for trading with warrants of series TO1: May 11 2022.
How to exercise warrants of series TO1:
Nominee-registered warrants (Custody account)
Subscription and payment for shares subscribed for through exercise of warrants shall be made in accordance with instructions from each nominee. Please contact your nominee for additional information.
Direct-registered warrants (Securities account)
No accounts for issuing nor any instructions regarding payments will be sent out. Subscription of shares shall be made through simultaneous payment in accordance with the instructions on the application form. The warrants will thereafter be replaced by interim shares awaiting registration at the Swedish Companies Registration Office.
Application form including payment instructions is available at the Companys website, www.emplicure.com and on Mangold Fondkommission ABs website www.mangold.se.
Advisors
Mangold Fondkommission AB is the financial advisor and issuing agent and Advokatfirman Lindahl KB is the legal advisor to Emplicure in connection with the exercise of the warrants.
For more information, please contact:
Torbjörn W. Larsson
CEO
Phone: +46 (0)70 747 65 99
Email: torbjorn.walkerlarsson@emplicure.com
Erik Magnusson
CFO, Investor Relations
Phone: +46 (0)708 565 245
Email: erik.magnusson@emplicure.com
Certified Adviser
Emplicure AB (publ) is listed on the Nasdaq First North Growth Market. Certified Adviser is Mangold Fondkommission AB, +46 8 503 015 50, or via ca@mangold.se
The following documents can be retrieved from beQuoted
PM-Last-day-for-trading-TO1-Emplicure-AB.pdf
Emplicure is a pharmaceutical company developing new and innovative drugs by combining existing and approved active substances, and advanced materials science within ceramic biomaterials. The product portfolio is focused on chronic pain, and with abuse deterrent formulations. The wholly owned subisidiary, Amplicon AB develops consumer products, with white tobacco-free nicotine pouches as the first product. Read more at www.emplicure.com